MedPath

Levels of Diagnostic and Therapeutic Intervention in Hospitalized Patients

Not Applicable
Not yet recruiting
Conditions
Acute Disease
Interventions
Other: Levels of Diagnostic and Therapeutic Intervention tool by Fontecha and col.
Other: Usual clinical practice
Registration Number
NCT06315842
Lead Sponsor
Consorci Sanitari de l'Alt Penedès i Garraf
Brief Summary

The objective of this clinical trial is to investigate the impact of implementing a tool for adjusting the level of diagnostic and therapeutic intensity in the clinical practice of physicians attending hospitalized patients.

The goal of this clinical trial is to investigate the impact of a tool for adjusting diagnostic and therapeutic intensity in hospitalized patients. The main question it aims to answer is: Is there a difference in patient mortality when using the aforementioned tool? The participating physicians will be grouped into 4 groups (5 physicians each). Each group will progressively (every 3 months) incorporate the use of the aforementioned tool into their usual clinical practice.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Physician belonging to the non-surgical medical area.
  • Routine clinical activity on a hospital ward caring for hospitalized patients.
Exclusion Criteria
  • Physician belonging to the Oncology-Hematology/Palliative Care Hospitalization Unit.
  • Refusal to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Levels of Diagnostic and Therapeutic Intervention toolLevels of Diagnostic and Therapeutic Intervention tool by Fontecha and col.Medical doctors assigned to this group will incorporate a Levels of Diagnostic and Therapeutic Intervention tool into their clinical practice
Usual clinical practiceUsual clinical practiceMedical doctors assigned to this group will continue their clinical practice as usual
Primary Outcome Measures
NameTimeMethod
In-hospital Patient Mortality at 90 days from hospital discharge90 days from hospital discharge

Percentage of patients who die during hospitalization until 90 days from hospital discharge.

Secondary Outcome Measures
NameTimeMethod
In-hospital Patient Mortality at 1 year from hospital discharge1 year from hospital discharge

Percentage of patients who die during hospitalization until 1 year from hospital discharge.

Healthcare expenditurethrough study completion, an average of 1.5 years

Descriptive analysis of healthcare expenditure associated with each intervention, using the billing data from the center.

Patients admitted to the Intensive Care Unit (ICU)hospital discharge, assessed up to day 90

Percentage of patients admitted to the ICU during hospitalization

Pressure Ulcer Incidencehospital discharge, assessed up to day 90

Percentage of patients with pressure ulcer occurrence during hospital admission (pressure ulcers already present at the time of admission will not be considered).

Hospital stayhospital discharge, assessed up to day 90

Hospital stay in days

Calls to the "on-call doctor"hospital discharge, assessed up to day 90

Number of calls to the "on-call doctor" during hospital admission

In-hospital Patient Mortality at 6 months from hospital discharge6 months from hospital discharge

Percentage of patients who die during hospitalization until 6 months from hospital discharge.

Hospital readmission for any reason30 days from hospital discharge

Percentage of patients readmitted for any reason within 30 days of hospital discharge.

Hospital readmission for same reason30 days from hospital discharge

Percentage of patients readmitted for the same reason within 30 days of hospital discharge.

Mortality at ICUhospital discharge, assessed up to day 90

Percentage of patients admitted to the ICU

Delirium Incidencehospital discharge, assessed up to day 90

Percentage of patients with delirium occurrence during hospital admission (delirium already present at the time of admission will not be considered). Delirium will be evaluated through Confusion Assessment Method (CAM)

Trial Locations

Locations (1)

Consorci Sanitari Alt Penedes i Garraf

🇪🇸

Vilafranca Del Penedès, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath